SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-083319
Filing Date
2020-03-24
Accepted
2020-03-24 09:33:04
Documents
9
Period of Report
2020-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d897508d8k.htm 8-K 29779
2 EX-1.1 d897508dex11.htm EX-1.1 198914
3 EX-4.1 d897508dex41.htm EX-4.1 128430
4 EX-4.2 d897508dex42.htm EX-4.2 130362
5 EX-5.1 d897508dex51.htm EX-5.1 14667
6 EX-99.1 d897508dex991.htm EX-99.1 11725
7 GRAPHIC g897508g0324062253216.jpg GRAPHIC 3297
8 GRAPHIC g897508g0324062535552.jpg GRAPHIC 2372
9 GRAPHIC g897508g0324130705890.jpg GRAPHIC 4362
  Complete submission text file 0001193125-20-083319.txt   529392
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 20736903
SIC: 8090 Services-Misc Health & Allied Services, NEC